Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO05032) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Taurine
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Approved/Marketed Drug
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1123"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Unclear metabolic mechanism (DME-unclear) | DME Info | Streptococcus mutans | [1] | |||
| Glutamate racemase (MurI) | DME Info | Streptococcus mutans | [1] | |||
| References | ||||||
| 1 | S-aryl-L-cysteine sulphoxides and related organosulphur compounds alter oral biofilm development and AI-2-based cell-cell communication. J Appl Microbiol. 2014 Nov;117(5):1472-86. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.